Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion in Anti-doping

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the proposed project is to perform a clinical study in which volunteers will receive autologous blood transfusions in DEHP-free blood bags.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using DNA-Typing and Erythrocyte Microparticle Analysis to Detect Blood Doping

NCT03548766

Blood Disease Blood Transfusion, Autologous Blood Doping +1 more

UNKNOWN PHASE3

Development of a Mass-spectometry Based Method for Detecting Xenon Application in Humans

NCT02105077

Anesthesia

COMPLETED

Study of the Excretion of Orally Administered Corticosteroids for the Improval of the Detection of Said Substances in Anti-doping Controls

NCT04791345

Healthy Volunteers

UNKNOWN PHASE1

Tracing Changed Production of Red Blood Cells

NCT05833477

Erythrocytosis Erythropoiesis Abnormal

COMPLETED NA

Impact of Antioxidant Agents on the Number of DNA Double-strand Breaks After Radiation-based Cardiac Examinations

NCT01578395

Focus of the Study: DNA Damage Due to Medical Diagnostic X-ray

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transfusion Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blood bags without DEHP

Intervention : Autologous blood transfusion

Group Type EXPERIMENTAL

Autologous blood transfusion

Intervention Type BIOLOGICAL

Volunteers make a blood donation and after 36 days of storage this blood is re-infused in the same volunteers.

Blood bags with DEHP

Intervention : Autologous blood transfusion

Group Type EXPERIMENTAL

Autologous blood transfusion

Intervention Type BIOLOGICAL

Volunteers make a blood donation and after 36 days of storage this blood is re-infused in the same volunteers.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Autologous blood transfusion

Volunteers make a blood donation and after 36 days of storage this blood is re-infused in the same volunteers.

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have to fill the swiss blood donation formulary

Exclusion Criteria

* Anemia
* Cardiovascular disease
* Neurologic disease
* Not performed a blood donation for 5 weeks ago the start of the study.
* Immunological disease

Minimum Eligible Age

20 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes